Cardiac Registry Readmission Rates Now Public
Readmissions data from an American College of Cardiology's registry is now posted on a federal website, in a move toward more public reporting of procedural outcomes.
Hospital Compare, the Medicare agency's website for public inspection of hospital quality, is now posting unique 30-day readmission rates for patients who underwent percutaneous coronary interventions or PCIs or angioplasty at 300 hospitals that volunteered to allow their data to be released.
The new section of the website shows whether those hospitals had better, worse, or average risk-adjusted readmission rates. The data comes from the American College of Cardiology's five-year-old NCDR CathPCI registry, which includes records of 15 million patient PCI procedures performed at 1,541 hospital catheterization labs in the country.
Prior to the federal release, the ACC shared this and other quality measures only with individual participating hospitals and researchers.
Gregory J. Dehmer, MD, chairman of the ACC's Public Reporting Advisory Group, says the purpose of the new release is to move toward more public reporting of such procedural outcomes. "This is about the rising tide that floats all boats; it's about all institutions doing better."
Dehmer says that the ACC decided to allow the Centers for Medicare & Medicaid Services to release readmissions data on this website, rather than rates for other PCI outcomes it collects such as perforations, stent thrombosis, subsequent heart failure, or 30-day mortality, because "readmission rates are a pretty hot topic right now" and because "substantial healthcare dollars can be saved by lowering readmission rates."
- Ebola: Health Officials Try to Quell Front Line Fears
- Reducing Readmissions Starts with Better Collaboration
- Ebola: A New Normal in Dallas
- Partners HealthCare M&A Deal Under Scrutiny
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Educated Nurses Save Money
- 'Overtreatment' Debate Circles Back to Lung Cancer Screening
- As virus spreads, insurers exclude Ebola from new policies
- How Top-Ranked MA Plans Earn Their Stars
- Defensive Medicine Still Prevalent Despite Tort Reform